Publication | Closed Access
Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma
45
Citations
19
References
2011
Year
DAB2IP is a valuable marker for progression of HCC patients. Downregulation of DAB2IP is associated with poor prognosis in HCC patients. DAB2IP silence alone is sufficient to promote HCC cell proliferation and invasion in vitro.
| Year | Citations | |
|---|---|---|
Page 1
Page 1